Hawaii Clinical Trials Report — April 2026

For residents of Hawaii considering participation in clinical research, April 2026 presents a critical opportunity to join studies that are nearing their enrollment deadlines. Across the islands, 15 clinical trials are scheduled to close within the next 90 days. This includes specific opportunities for healthy volunteers, with 4 of these time-sensitive studies actively seeking individuals without particular health conditions. Those interested in contributing to medical advancements should act swiftly to explore these options before they are no longer available.

Patients managing certain health conditions also have a limited window to enroll in ongoing research. Trials focused on various types of cancer, infectious diseases, and other conditions are among those with impending deadlines. Conditions with trials closing soon include:

• Stage IV lung cancer (AJCC V8)
• Breast cancer
• Contraception
• Chemotherapy-induced peripheral neuropathy (CIPN)
• Chlamydia
• Colon cancer
• Cannabis use
• Gastric cancer
• Gastroesophageal junction cancer
• Gonorrhea

These studies offer a chance to access investigational treatments or interventions that could impact future care. Reviewing eligibility criteria and contacting research sites promptly is essential for anyone considering these options.

New Research Initiatives Take Root in Hawaii

This month, Hawaii welcomes 2 new clinical trials, offering fresh avenues for participation in medical research. While this number is consistent with the 2 new trials that opened in March 2026, these new studies address important community health needs and bring new opportunities for residents.

The new trials are sponsored by significant local institutions, underscoring Hawaii's commitment to health innovation. Tripler Army Medical Center is sponsoring one new trial, while Waianae Coast Comprehensive Health Center is leading the other. These organizations play a vital role in providing healthcare and advancing research within the state.

The conditions being explored by these new studies are diverse, focusing on areas relevant to community well-being:

• Adolescent asthma
• Asthma
• Chronic disease
• Obesity & overweight
• Prediabetes
• Rhabdomyolysis
• Youth mental health
• Youth obesity

One of the new trials is classified as a behavioral intervention, exploring how lifestyle changes or psychological approaches can impact health outcomes. The other is a procedure-based study, investigating new medical techniques or interventions. These varied approaches ensure that research opportunities cater to different aspects of health and wellness.

Opportunities for Healthy Volunteers and Diverse Participants

A significant highlight this month is the continued demand for healthy volunteers. Of the 2 new trials launched in April, 1 is actively seeking individuals without specific health conditions. This is a valuable opportunity for those who wish to contribute to medical science and help establish baseline data for new treatments or diagnostic methods, even if they do not have a particular illness.

Across Hawaii, the opportunities for healthy volunteers extend beyond the new trials, with a total of 26 studies currently recruiting individuals without specific health conditions. These trials are crucial for a wide range of research, from understanding normal physiological processes to testing the safety of new interventions.

Eligibility for the new trials is also inclusive: 1 of the new studies includes children, and 1 includes older adults. This ensures that research benefits a broad spectrum of the population, addressing health concerns across different age groups. No new trials this month are exclusively for female or male participants.

Hawaii's Expansive Research Landscape

Overall, Hawaii continues to be a vibrant hub for clinical research, with a total of 217 clinical trials currently recruiting participants. These studies are distributed across 16 cities and conducted at 99 research sites throughout the state, ensuring broad accessibility for residents.

This month's new trials are located in key areas: 1 new trial opened at Tripler Army Medical Center (TAMC), and another 1 opened in Waianae. This geographic distribution reflects a commitment to bringing research opportunities to different communities across the islands, rather than concentrating them in a single metropolitan area.

The presence of nearly 100 research sites means that individuals across Hawaii have various options for participating in studies close to home. This widespread availability is crucial for ensuring that diverse populations can contribute to medical advancements and benefit from access to cutting-edge care.

As we look ahead, the ongoing recruitment for these 217 trials, coupled with the consistent introduction of new studies, promises continued opportunities for Hawaii residents to engage with and benefit from clinical research. The focus on community health initiatives by local sponsors suggests a future where research directly addresses the unique needs of the island population.